Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

Janney Montgomery Scott analyst Michael Gaugler downgrades South Jersey Indus (NYSE:SJI) from Buy to Neutral.

byBenzinga Newsdesk

January 9, 2023

1 minute read

Janney Montgomery Scott analyst Michael Gaugler downgrades South Jersey Indus (NYSE:SJI) from Buy to Neutral.

William Blair Upgrades FibroGen to Outperform

By Benzinga Newsdesk

Today, 3:27 AM

William Blair analyst Andy Hsieh upgrades FibroGen (NASDAQ:FGEN) from Market Perform to Outperform.

FGEN

HC Wainwright & Co. Initiates Coverage On Histogen with Buy Rating, Announces Price Target of $2.4

By Benzinga Newsdesk

Today, 3:27 AM

HC Wainwright & Co. analyst Douglas Tsao initiates coverage on Histogen (NASDAQ:HSTO) with a Buy rating and announces Price Target of $2.4.

HSTO

Credit Suisse Maintains Neutral on Fortis, Raises Price Target to C$57

By Benzinga Newsdesk

Today, 3:27 AM

Credit Suisse analyst Andrew Kuske maintains Fortis (TSX:FTS) with a Neutral and raises the price target from C$56.5 to C$57.

TSX:FTS

Stryve Foods Q2 Sales $7.35M Up From $4.28M YoY

By Benzinga Newsdesk

Today, 3:27 AM

Stryve Foods (NASDAQ:SNAX) reported $7.35 million in sales this quarter. This is a 71.79 percent increase over sales of $4.28 million the same period last year.

SNAX

Janney Montgomery Scott Downgrades South Jersey Indus to Neutral

Related Posts

William Blair Upgrades FibroGen to Outperform

HC Wainwright & Co. Initiates Coverage On Histogen with Buy Rating, Announces Price Target of $2.4

Credit Suisse Maintains Neutral on Fortis, Raises Price Target to C$57

Stryve Foods Q2 Sales $7.35M Up From $4.28M YoY